Autoimmune Disorders: Bristol Myers Squibb has entered into a research agreement with Repertoire to develop vaccines for ...

The "Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies" report has been added to ResearchAndMarkets.com's offering.The report ...

Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. | Abbott has ...

Following the US approval of the Agent paclitaxel-coated balloon for the treatment of in-stent restenosis (ISR), the first coronary procedures with the device were performed Tuesday morning at two ...

Treatment marks the first dissolving stent approved in the United States for treating chronic limb-threatening ischemia in ...

(RTTNews) - Abbott Laboratories (ABT) Monday announced that the U.S. Food and Drug Administration has approved the Esprit BTK Everolimus Eluting Resorbable Scaffold System for patients suffering from ...

The US Food and Drug Administration has approved Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ...

First-of-its-kind, Esprit BTK Everolimus Eluting Resorbable Scaffold System is designed to keep treat chronic ...

Abbott introduces XIENCE Sierra stent system in India, offering advanced features to treat complex cardiovascular cases ...

Commenting on the launch of the coronary stent system, Tushar Sharma, general manager for Abbott’s vascular business in India ...

People who've survived a heart attack and have been given a stent may be better off quitting low-dose aspirin a month after the procedure, a new study finds. The strategy is "beneficial by ...

There has been an ongoing debate regarding which duplex ultrasound (DUS) criteria to use to determine the rate of in-stent restenosis. This prospective study revisits DUS criteria for determining ...